Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotech IPOs: Why Values Will Increase

May 01 2007

• By Roger Longman

Related Content

Reviewing Five Years of Big Pharma's Biotech Acquisitions

May 01 2007

The Price is Wrong: Finding Alternatives to Traditional IPOs

Jun 01 2006

Related Companies

Gyre Therapeutics, Inc.

Alexza Pharmaceuticals, Inc.

Vanda Pharmaceuticals, Inc.

Cadence Pharmaceuticals, Inc.

Osiris Therapeutics, Inc.

Morphotek

Eisai Co., Ltd.

Orexigen Therapeutics, Inc.

Arena Pharmaceuticals, Inc.

Vivus, Inc.

CymaBay Therapeutics, Inc.

Johnson & Johnson

Madrigal Pharmaceuticals, Inc.

Perlegen Sciences, Inc.

FibroGen, Inc.

Additional Topics

Business Strategies Leadership BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window